NASDAQ Global Select • Healthcare • Biotechnology • US • USD
Aktis Oncology, Inc. (AKTS) has a market capitalization of $952.71M and trades at $17.84. The 52-week range is 14.72-29.16.
Key metrics include annual revenue of $6.5M.
The stock has a beta of 0.00, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
